FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/05/019123 [Registered on: 14/05/2019] Trial Registered Prospectively
Last Modified On: 08/07/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   clinical evaluation of Parangichakkai chooranam (internal) and Karappan ennai(external)in the treatment of Balakarappan(Atopic dermatitis) in children. 
Scientific Title of Study   Clinical Evaluation of PARANGICHAKKAI CHOORANAM(Internal) and KARAPPAN ENNAI(External)in the treatment of BALAKARAPPAN (Atopic dermatitis) in children. 
Trial Acronym  Atopic dermatitis 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSKalaivani 
Designation  PG Scholar 
Affiliation  National institute of siddha 
Address  Department of kuzhandhai maruthuvam, Ayothidoss pandithar hospital, National institute of siddha Tambaram sanatorium,chennai, kancheepuram-600047
Department of kuzhandhai maruthuvam, Ayothidoss pandithar hospital, National institute of siddha, Tambaram sanatorium, chennai, kancheepuram -600047
Kancheepuram
TAMIL NADU
04422381314
India 
Phone  9790146119  
Fax  04422381314  
Email  drkalaivanibsms@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrMMeenakshi sundaram 
Designation  Head of the Department 
Affiliation  NationaL Institute of siddha 
Address  Department of kuzhandhai maruthuvam, Ayothidoss pandithar hospital, National institute of siddha, Tambaram sanatorium,chennai kancheepuram -600047
Department of kuzhandhai maruthuvam, Ayothidoss pandithar hospital, National institute of siddha, Tambaram sanatorium,chennai kancheepuram -600047
Kancheepuram
TAMIL NADU
04422381314
India 
Phone  9444214582  
Fax  04422381314  
Email  mmssiddha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrMMeenakshi sundaram 
Designation  Head of the Department 
Affiliation  NationaL Institute of siddha 
Address  Department of kuzhandhai maruthuvam, Ayothidoss pandithar hospital, National institute of siddha, Tambaram sanatorium,chennai kancheepuram -600047
Department of kuzhandhai maruthuvam, Ayothidoss pandithar hospital, National institute of siddha, Tambaram sanatorium,chennai kancheepuram -600047
Kancheepuram
TAMIL NADU
04422381314
India 
Phone  9444214582  
Fax  04422381314  
Email  mmssiddha@gmail.com  
 
Source of Monetary or Material Support  
Dr.s.kalaivani 
 
Primary Sponsor  
Name  Ayothidoss pandithar hospital 
Address  National institute of siddha Tambaram sanatorium kancheepuram 
Type of Sponsor  Other [research student] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
drskalaivani  Ayothidoss pandithar hospital  Department of kuzhandhai maruthuvam,Ayothidoss pandithar hospital,National institute of siddha,Tamabaram sanatorium,chennai
Kancheepuram
TAMIL NADU 
9790146119
04422381314
drkalaivanibsms@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L209||Atopic dermatitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  parangichakkai chooranam(internal) and karappan ennai(external)  parangichakkai chooranam,5to6 years-1.3gm,7to12years-2gm will be administrated orally,afterfood twice a day and karappan ennai( required quantity) will be applied extrenally in the affected areas. 
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  children of both sexes in the age group of 5 to 12 years with symptoms of:
1.Erythema
2.Edema
3.Oozing
4.Itching
5.Crusting and Scaling
6.Lichenified plaque 
 
ExclusionCriteria 
Details  1.Scabies
2.photodermatitis
3.Fungal and parasitic skin infection
4.Psoriasis
5.Any other serious illness 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
to evaluate the efficacy of Parangichakkai chooranam (Internal) and Karappan ennai(external)in the treatment of Balakarappan(Atopic dermatitis) using EASI Score  1 to 45 days 
 
Secondary Outcome  
Outcome  TimePoints 
to standardize the physico chemical properties of the trial drugs.
To study the effect of trial drug in reducing the frequency of incidence ofBalakarappan 
3 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/05/2019 
Date of Study Completion (India) 06/03/2020 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   IT Is a single non randomized open -label trial to determine the efficacy of PARANGICHAKKAI CHOORANAM (internal medicine) with KARAPPAN ENNAI (external medicine) in patients with BALAKARAPPAN(Atopic dermatitis). In the trial 30 Atopic dermatitis patients will be recruited and the trial drug parangichakkai chooranam , 5 to 6 years -1.3gm and 7 to 12 years -2gm, will be administrated orally after food twice a day and karappan ennai ( required quantity) will be applied for affected skin for a periods of 45 days.During the study period all the study related data will be recorded and documented in separate trial master file for each and every patients.During the trial period if the patient develop any adverse effect he/she will be immediately referred to the chairman, pharmaco- vigilance committee, NIS. If it will be mild event , the patient will be treated in OPD-NIS. If thr event will be reserve , the patient will be reffered to nearby Government Hospital and investigator will be take over the patient,until he/she will get recovery. the treatment will be provided with free of cost. the entire trial will be monitored by the research monitoring committee of NIS. After completion of the trial all the study related data will be analysed statistically. The outcome of this trial will be published in Indian journal of Medicial research. 
Close